The goals of this project are: (1) to elucidate the structure of the site(s) on neuronal nicotinic acetylcholine receptors (nAChRs) where zinc binds and potentiates receptor function, and (2) to elucidate the mechanism through which zinc potentiates receptor function. ? Nicotinic ligands are potentially useful as anxiolytics and analgesics, in the treatment of neurological disorders such as schizophrenia, Parkinson's disease, and Alzheimer's disease, and are also the sites at which nicotine exerts its psychoactive and addictive effects. Effective pharmacological intervention at neuronal nAChRs requires development of subtype selective ligands. Pursuit of this goal has traditionally been directed toward development of ligands that act at the acetylcholine (ACh) binding sites. We propose to pursue a new class of site on neuronal nAChRs, the site at which zinc potentiates these receptors. The ACh binding sites on neuronal nAChRs are at the interfaces between the extracellular domains of subunits. In many neuronal nAChRs, two agonist-binding sites are formed at interfaces between two pairs of dissimilar subunits, leaving three alternate interfaces with no involvement in ACh binding. We hypothesize that one or more of the alternate interfaces bind zinc, a modulator of neuronal nAChR function.
In aim 1, we will use site-directed mutagenesis and functional analysis to identify amino acid residues on neuronal nAChRs that coordinate zinc at the potentiation site.
In aim 2, we will explore the larger structure of the potentiation site using Substituted Cysteine Accessibility Mutagenesis. Information obtained in aims 1 and 2 will be used to refine a homology model of the extracellular domains of neuronal nAChRs.
In aim 3, we will determine whether zinc potentiates neuronal nAChRs through changes in the single channel open probability, the single channel current, and/or the number of channels. Changes in open probability will be characterized in terms of the underlying gating mechanism. ? ? ?

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Nadler, Laurie S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
Coral Gables
United States
Zip Code
Repicky, Sarah E; Luetje, Charles W (2009) Molecular receptive range variation among mouse odorant receptors for aliphatic carboxylic acids. J Neurochem 109:193-202
Hsiao, Bernard; Mihalak, Karla B; Magleby, Karl L et al. (2008) Zinc potentiates neuronal nicotinic receptors by increasing burst duration. J Neurophysiol 99:999-1007
Abaffy, Tatjana; Malhotra, Arun; Luetje, Charles W (2007) The molecular basis for ligand specificity in a mouse olfactory receptor: a network of functionally important residues. J Biol Chem 282:1216-24
Wanner, Kevin W; Nichols, Andrew S; Walden, Kimberly K O et al. (2007) A honey bee odorant receptor for the queen substance 9-oxo-2-decenoic acid. Proc Natl Acad Sci U S A 104:14383-8
Menashe, Idan; Abaffy, Tatjana; Hasin, Yehudit et al. (2007) Genetic elucidation of human hyperosmia to isovaleric acid. PLoS Biol 5:e284
Mihalak, Karla B; Carroll, F Ivy; Luetje, Charles W (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-5
Hsiao, Bernard; Mihalak, Karla B; Repicky, Sarah E et al. (2006) Determinants of zinc potentiation on the alpha4 subunit of neuronal nicotinic receptors. Mol Pharmacol 69:27-36
Abaffy, Tatjana; Matsunami, Hiroaki; Luetje, Charles W (2006) Functional analysis of a mammalian odorant receptor subfamily. J Neurochem 97:1506-18